Final results from the phase 2 SUMMIT basket trial: targeting HER2+ advanced BTCs with neratinib Published 2022-06-09 Download video MP4 360p Recommendations 03:38 Vaccine Therapy to Prevent Recurrences in HER2-Positive Breast Cancer 02:51 Preventing brain metastases in patients with HER2+ or triple negative breast cancer 01:08 Biomarker directed therapies in biliary tract cancers 01:20 Updated results of DESTINY-Breast03: T-DXd vs T-DM1 in metastatic HER2+ breast cancer 04:53 AACR 2023 highlights on advances in the treatment of biliary tract cancer with Robin Katie Kelley 03:14 NCI-MATCH/EAY131 Precision Medicine Cancer Trial – Spring 2021 Update 10:08 NCI-MATCH: Pioneering a New Era in Cancer Treatment 02:21 Final analysis of KEYNOTE-585: pembrolizumab and chemotherapy in G/GEJ cancer 01:44 The cure for hiccups that works every, single time 24:10 Dr. Maryanne Demasi - 'Statin Wars: Have we been misled by the evidence?' 34:08 My Chronic Lyme Disease Journey PT. 3 | Symptoms | Antibiotics | Breaking Point | Recovery 01:29 What happens when your nose runs 13:50 4 Tricks for when doctors gaslight you - Dr. Kaveh LIVE 13:34 Why more young people are dying of bowel cancer | ABC News Daily podcast 06:06 Ravi's Bladder Cancer Story 09:15 Why Am I Always Tired? Avoid These 6 Energy Vampires | Exhausted 14:46 Excess Deaths at Night - Obstructive Sleep Apnea Explained Clearly 01:22 Most Common Symptoms of PTSD - 18:40 Matthew Perry's Death From Ketamine Explained (Is It Safe For You?) 01:12 How much water should you drink a day? Similar videos 04:52 Neratinib + fulvestrant + trastuzumab for HR+ HER2-mutant mBC and neratinib + trastuzumab for tr... 01:51 ELEANOR interim analysis: real-world study of adjuvant neratinib in HER2+/HR+ early breast cancer 01:01 Are You Worried About HER2+ Breast Cancer Recurrence? 01:53 Optimal Timing for Neratinib 01:37 Dr. Traina on Conversations on Extended Adjuvant Therapy With Neratinib in HER2+ Breast Cancer 02:34 ELEANOR: real-world use of neratinib in HER2+, early breast cancer 00:56 Dr. Jhaveri Discusses the Utility of T-DM1 in the Neoadjuvant Setting 1:21:56 Understanding the HER2 Story in Gastrointestinal Malignancies: A GEA and BTC Focus 07:23 Studio ERMES: il ruolo di cetuximab nella terapia di mantenimento del mCRC More results